PHILADELPHIA, PA, UNITED STATES, February 4, 2026 /EINPresswire.com/ — RxParadigm, an end-to-end 340B drug administration platform with integrated capabilities to ...
The MarketWatch News Department was not involved in the creation of this content. Guideline Supports Consistent Application of GS1 Standards to Improve Data Accuracy and Visibility in the Healthcare ...
The American Hospital Association is urging CMS to adjust its newly established drug price negotiation program, arguing the agency’s current approach conflicts with 340B programs. In a May 1 open ...
Examining the drivers of 340B drug program growth, the impact of vertical integration and contract pharmacies, the ongoing legal and regulatory disputes, and the strategic considerations life sciences ...
Providers and drugmakers are once again at odds over the 340B drug discount program: this time, over a rule finalized by the Biden administration on Thursday making changes to its dispute resolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results